HFA Premium Access

Short-term effects of dapagliflozin on peak VO2 in heart failure and reduced ejection fraction (DAPA-VO2): a randomized clinical trial

Congress Presentation

About the speaker

Doctor Julio Nunez Villota

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)
11 presentations
1 follower

4 more presentations in this session

The safety and efficacy of istaroxime for PreCardiogenic Shock

Speaker: Professor M. Metra (Brescia, IT)


DIAMOND Trial: Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for Heart Failure with Reduced Ejection Fraction

Speaker: Professor B. Pitt (Ann Arbor, US)


EMPULSE - EMPagliflozin in patients hospitalized with acUte heart faiLure who have been StabilizEd

Speaker: Professor P. Ponikowski (Wroclaw, PL)


FIDELITY: Effect of finerenone by LVH subgroup

Speaker: Professor G. Filippatos (Athens, GR)


Access the full session

Late-Breaking Trials - Pharmacological treatment II

Speakers: Doctor J. Nunez Villota, Professor M. Metra, Professor B. Pitt, Professor P. Ponikowski, Professor G. Filippatos

About the event


Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb